Salasguevara v. Frye

31 Cal. App. 4th 330, 37 Cal. Rptr. 2d 40, 95 Daily Journal DAR 338, 95 Cal. Daily Op. Serv. 213, 1995 Cal. App. LEXIS 7
CourtCalifornia Court of Appeal
DecidedJanuary 5, 1995
DocketD016780
StatusPublished

This text of 31 Cal. App. 4th 330 (Salasguevara v. Frye) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Salasguevara v. Frye, 31 Cal. App. 4th 330, 37 Cal. Rptr. 2d 40, 95 Daily Journal DAR 338, 95 Cal. Daily Op. Serv. 213, 1995 Cal. App. LEXIS 7 (Cal. Ct. App. 1995).

Opinion

Opinion

NARES, J.

Question Presented

The proper standard of care for a person administering a diphtheria, pertussis and tetanus (DPT) vaccine to an infant is the sole legal question in this appeal. Trying the case without a jury, the court entered judgment in favor of Frederick Frye, M.D., in the medical malpractice action of Jaridijon Salasguevara, a minor by his guardian ad litem, 1 arising from Frye’s administration of DPT shots beginning when Dijon was one week short of four months old. The court applied a standard of care under Health and Safety Code 2 section 429.36, relating to liability for administering an immunizing agent to a minor, requiring the plaintiff to prove gross negligence or willful misconduct where the immunization is required by state law. On appeal Dijon contends ordinary negligence principles should apply with the result we should enter judgment for him on the basis of the trial court’s statement Frye breached the ordinary standard of care for physicians. We affirm.

Factual Background

Dijon was bom September 24, 1980. His birth and initial development were normal. His mother routinely took Dijon to his pediatricians, Frye and Ronald G. Lehman, M.D., for well baby visits, checkups and vaccinations.

At his three-month visit to Lehman, Dijon had a cold, as a result of which Lehman waited until the next regularly scheduled visit on January 15, 1981, to give him the first in a series of DPT vaccinations to immunize him against diphtheria, pertussis (whooping cough) and tetanus. Dijon showed no adverse reaction to the first shot.

On January 24, 1981, Frye, board certified in pediatrics since 1964, saw Dijon for the first time and prescribed Ampicillin and Dimetapp medications *333 for him due to an upper respiratory problem, irritation of the eustachian tube and ear infection. The next day, while he was waiting to be fed, Dijon had his first convulsion and was admitted to the hospital for two days.

As a result of another seizure Dijon was hospitalized for 11 hours on February 20, 1981. Again he was hospitalized for a seizure on February 26 and he suffered two additional seizures during his treatment until his release March 3, 1981.

On March 9, 1981, Frye gave Dijon a second DPT shot, and 20 hours later, on March 10, Dijon had another seizure. As of March 9, eight days had passed since Dijon’s last seizure, and he had been released from the hospital for six days.

Between the time of his first seizure January 25, 1981, and March 15, 1981, Dijon was given multiple electroencephalograms (EEG’s), spinal taps, a CT scan and blood work, none of which revealed the cause of his seizures. John H. Menkes, M.D., board certified in pediatrics and neurology, was of the opinion Dijon had an “evolving neurologic disorder” 3 as of March 9, 1981. John Tilelli, M.D., board certified in pediatrics, pediatric critical care and medical toxicology, also diagnosed Dijon as having an evolving neurologic disorder as of March 9, 1981.

Tilelli testified that giving the second DPT vaccination shot on March 9, 1981, was “strictly contraindicated.” Board-certified pediatrician Jeanette Wilkins, M.D., testified that under the circumstances of Dijon’s history, giving the second shot was “absolutely contraindicated.” Medical literature, including the DPT manufacturer’s package insert and the Red Book of the American Academy of Pediatricians, suggested that administration of DPT to a child with an evolving neurologic disorder is below the standard of care.

During Dijon’s 11-hour hospitalization on February 20, 1981, he was given Phenobarbital intravenously to control the seizures. On Dijon’s release Frye prescribed Phenobarbital to prevent him from having further seizures. Again after Dijon’s return to the hospital on February 26, 1981, he was given Phenobarbital during his stay. Frye’s notes of the February 26 hospital admission due to an additional seizure state, “Parents apparently have not given phenobarb [.sic] as ordered following discharge.” Phenobarbital was again prescribed on Dijon’s discharge March 3, 1981, but Frye expressed *334 doubt the parents gave Dijon any Phenobarbital on March 10,1981, when he asked Dijon’s mother to increase the dose as a result of the additional seizure 20 hours after the second DPT shot was given. Frye apparently believed Dijon’s seizure disorder was under control at the time of the second shot although there were the above stated indications Dijon’s father and mother were reluctant to give the necessary Phenobarbital. Frye believed the seizures were not caused by the DPT and would not have given the vaccination with the pertussis component if he had thought otherwise. Frye thought the risks of getting pertussis were greater than the 1-in-320,000 risk of encephalopathy. Michael J. Sexton, M.D., Dijon’s physician from October 1982 to the time of trial in August 1991, diagnosed Dijon’s condition as seizure disorder and developmental delaying and retardation, a diagnosis that is not related to the immunizations. Frye’s expert, pediatrician Paul F. Wherle, M.D., a specialist in infectious diseases and immunology, opined that the second DPT shot was proper and Frye complied with the standard of care.

There was additional conflicting evidence on the question of Frye’s compliance with the standard of care in administering the second DPT shot, and on causation.

A month before the August 1991 trial Dijon experienced two seizures for which his Phenobarbital dose was increased. He had another seizure over two years before the July 1991 episodes. The continued treatment of Dijon was to try to maintain therapeutic blood levels of anticonvulsants. As of the trial Dijon was extremely and permanently retarded, both mentally and physically.

Trial Court Decision

In its statement of decision, the trial court found that DPT immunization is required under section 3381, and thus the willful misconduct or gross negligence standard of section 429.36 applies. Applying the gross negligence standard to Frye’s conduct the court concluded: “The Court finds Dr. Frye’s conduct in administering the second DPT shot was not grossly negligent nor was it an extreme departure from the standard of care. Dr. Frye considered the risks to Jaridijon in administering the DPT shot and he considered the benefits of the shot. He believed Jaridijon did not have an evolving neurologic condition which contraindicated the administration of pertussis. This conclusion, although contrary to the Court’s finding, is not grossly negligent. As noted above, even the experts with the benefit of a leisurely, scholarly study were unable to agree as to what constituted an evolving neurologic condition and were unable to agree on whether the second shot was contraindicated.”

*335

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Select Base Materials, Inc. v. Board of Equalization
335 P.2d 672 (California Supreme Court, 1959)
Flood v. Wyeth Laboratories, Inc.
183 Cal. App. 3d 1272 (California Court of Appeal, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
31 Cal. App. 4th 330, 37 Cal. Rptr. 2d 40, 95 Daily Journal DAR 338, 95 Cal. Daily Op. Serv. 213, 1995 Cal. App. LEXIS 7, Counsel Stack Legal Research, https://law.counselstack.com/opinion/salasguevara-v-frye-calctapp-1995.